Express News | NYSE Order Imbalance 55025.0 Shares on Buy Side
DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
DaVita's (NYSE:DVA) Investors Will Be Pleased With Their Stellar 206% Return Over the Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, if you buy shares in a high quality company at the ri
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Top Gap Ups and Downs on Friday: CRM, INTU, NOW and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
Barclays analyst Andrew Mok CFA maintains $DaVita(DVA.US)$ with a hold rating, and maintains the target price at $150.According to TipRanks data, the analyst has a success rate of 46.1% and a total av
Novo Weight Loss Therapy Cuts Mortality Risk in Kidney Disease
A Look At The Intrinsic Value Of DaVita Inc. (NYSE:DVA)
Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now
Why DaVita HealthCare (DVA) Is a Top Momentum Stock for the Long-Term
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Reasons to Add HealthEquity (HQY) Stock to Your Portfolio
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Masimo's (MASI) New Offering to Serve Personalized Audio Market
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over dialysis group Fresenius Medical Care AG (NYSE:FMS). The investo
No Data